102 related articles for article (PubMed ID: 3473645)
1. Immunopathologic mechanisms of inflammatory vascular disease in primary Sjögren's syndrome--a model.
Alexander EL
Scand J Rheumatol Suppl; 1986; 61():280-5. PubMed ID: 3473645
[TBL] [Abstract][Full Text] [Related]
2. Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Model for human vasculitis in connective tissue disease.
Alexander EL; Moyer C; Travlos GS; Roths JB; Murphy ED
Arthritis Rheum; 1985 Oct; 28(10):1146-55. PubMed ID: 4052126
[TBL] [Abstract][Full Text] [Related]
3. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
Haneji N; Hamano H; Yanagi K; Hayashi Y
J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome.
Soyfoo MS; Steinfeld S; Delporte C
Oral Dis; 2007 Jul; 13(4):366-75. PubMed ID: 17577322
[TBL] [Abstract][Full Text] [Related]
5. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
7. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
8. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
9. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome. Cutaneous, immunologic, and nervous system manifestations.
Provost TT; Vasily D; Alexander E
Neurol Clin; 1987 Aug; 5(3):405-26. PubMed ID: 3306333
[TBL] [Abstract][Full Text] [Related]
11. Ocular inflammation in autoimmune MRL/Mp mice.
Jabs DA; Alexander EL; Green WR
Invest Ophthalmol Vis Sci; 1985 Sep; 26(9):1223-9. PubMed ID: 4030250
[TBL] [Abstract][Full Text] [Related]
12. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis.
Alexander EL
Rheum Dis Clin North Am; 1993 Nov; 19(4):869-908. PubMed ID: 8265827
[TBL] [Abstract][Full Text] [Related]
13. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
[TBL] [Abstract][Full Text] [Related]
14. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
Tzioufas AG; Voulgarelis M
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
[TBL] [Abstract][Full Text] [Related]
15. The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
Ramos-Casals M; Brito-Zerón P; Font J
Semin Arthritis Rheum; 2007 Feb; 36(4):246-55. PubMed ID: 16996579
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome: immunological response underlying the disease.
Brayer JB; Humphreys-Beher MG; Peck AB
Arch Immunol Ther Exp (Warsz); 2001; 49(5):353-60. PubMed ID: 11798133
[TBL] [Abstract][Full Text] [Related]
18. Celiac disease and markers of celiac disease latency in patients with primary Sjögren's syndrome.
Iltanen S; Collin P; Korpela M; Holm K; Partanen J; Polvi A; Mäki M
Am J Gastroenterol; 1999 Apr; 94(4):1042-6. PubMed ID: 10201480
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjögren's syndrome model mice.
Nishiyama T; Mishima K; Obara K; Inoue H; Doi T; Kondo S; Saka M; Tabunoki Y; Hattori Y; Kodama T; Tsubota K; Saito I
Clin Exp Immunol; 2007 Sep; 149(3):586-95. PubMed ID: 17614971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
